Skip to main content
Clinical Trials/NCT02484326
NCT02484326
Completed
Not Applicable

Development and Validation of a Clinical Risk Score Predicting the Cardiac Rupture in Patients With ST-elevation Myocardial Infarction

Chinese PLA General Hospital1 site in 1 country3,779 target enrollmentJanuary 2012
ConditionsCardiac Rupture

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Rupture
Sponsor
Chinese PLA General Hospital
Enrollment
3779
Locations
1
Primary Endpoint
Incidence of cardiac rupture
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to validate a practical risk score to predict the mechanical complication of ST-elevation myocardial infarction (STEMI).

Detailed Description

STEMI patients chewed 300 mg aspirin and 600 mg clopidogrel in the emergency department, followed by oral 100 mg aspirin and 75mg clopidogrel daily for at least 12 months. STEMI patients received low molecular weight heparin (LMWH), β-blockers, and angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) according to the STEMI guideline, unless there were contraindications to these drugs. Peripheral blood samples were collected from patients within 2 hours of admission for blood routines and blood biochemistry examinations. White blood cell counts and level of hemoglobin were assessed with automated cell counters via standard techniques. The investigators followed up patients in validation group for three month to observe the cardiac rupture events and other adverse cardiac events .

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
January 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chinese PLA General Hospital
Responsible Party
Principal Investigator
Principal Investigator

Qian geng

MD

Chinese PLA General Hospital

Eligibility Criteria

Inclusion Criteria

  • ST-elevation myocardial infarction: concurrence of symptoms (chest pain or symptoms compatible with acute heart failure or unexplained syncope) and electrocardiogram findings (new onset left bundle branch block or ST-segment elevation≥1 mm in ≥2 inferior leads or ≥2 mm in ≥2 precordial leads)

Exclusion Criteria

  • cancer mental illness

Outcomes

Primary Outcomes

Incidence of cardiac rupture

Time Frame: 3 month

Pericardial tamponade or electromechanical dissociation accompanied with massive pericardial effusion is the indicator of cardiac rupture

Study Sites (1)

Loading locations...

Similar Trials